Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Interferons
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Chemohormonal and Immunohormonal Approaches in Advanced Prostatic Carcinoma
Available to PurchaseSubject Area:
Further Areas
Journal:
European Urology
European Urology (1993) 24 (Suppl. 2): 81–86.
Published Online: 11 August 2017
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chemohormonal therapy Immunohormonal therapy Prostate cancer Carcinoma, prostatic Interferons Chemotherapy Flutamide Androgen blockade, total 11 8 2017 Eur Urol...
Journal Articles
Interferon–Alpha Suppresses the Antiapoptotic Effect of NF–kB and Sensitizes Renal Cell Carcinoma Cells in vitro to Chemotherapeutic Drugs
Available to PurchaseSubject Area:
Further Areas
Journal:
European Urology
European Urology (2001) 39 (4): 478–483.
Published Online: 02 April 2001
...T. Steiner; U. Junker; B. Henzgen; K. Nuske; S.K. Durum; J. Schubert Background: Immunochemotherapy (ICT) with interleukin–2 (IL–2) and interferon–α (IFNα) with a secondary effector (5–fluorouracil, 5 FU) is the only promising treatment for advanced renal cell carcinoma (RCC). With IFNα, besides...
